Walgreens Boots Alliance, Inc. (W8A.DE)
EUR 9.58
(4.42%)
EUR 9.58
(4.42%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -11.27 Billion USD | -336.79% |
| 2023 | -2.58 Billion USD | -140.5% |
| 2022 | 6.37 Billion USD | 16.89% |
| 2021 | 4.87 Billion USD | 64.82% |
| 2020 | 2.98 Billion USD | -54.48% |
| 2019 | 7.04 Billion USD | -13.06% |
| 2018 | 8.36 Billion USD | 16.13% |
| 2017 | 7.2 Billion USD | -3.46% |
| 2016 | 7.45 Billion USD | -2.61% |
| 2015 | 7.65 Billion USD | 52.28% |
| 2014 | 5.02 Billion USD | -5.52% |
| 2013 | 5.32 Billion USD | 14.97% |
| 2012 | 4.63 Billion USD | -15.06% |
| 2011 | 5.45 Billion USD | 21.46% |
| 2010 | 4.48 Billion USD | 6.3% |
| 2009 | 4.22 Billion USD | -1.37% |
| 2008 | 4.28 Billion USD | 11.87% |
| 2007 | 3.82 Billion USD | 16.89% |
| 2006 | 3.27 Billion USD | 12.65% |
| 2005 | 2.9 Billion USD | 14.89% |
| 2004 | 2.54 Billion USD | 16.85% |
| 2003 | 2.2 Billion USD | 12.44% |
| 2002 | 1.93 Billion USD | 17.01% |
| 2001 | 1.66 Billion USD | 15.82% |
| 2000 | 1.45 Billion USD | 15.93% |
| 1999 | 1.22 Billion USD | 24.16% |
| 1998 | 1.02 Billion USD | 13.97% |
| 1997 | 872.6 Million USD | 16.04% |
| 1996 | 751.4 Million USD | 15.4% |
| 1995 | 651.6 Million USD | 13.78% |
| 1994 | 573.8 Million USD | 11.28% |
| 1993 | 510.9 Million USD | 15.99% |
| 1992 | 450.6 Million USD | 11.07% |
| 1991 | 405.5 Million USD | 14.35% |
| 1990 | 354.6 Million USD | 11.76% |
| 1989 | 317.3 Million USD | 11.88% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 971 Million USD | 107.85% |
| 2024 Q2 | 7 Million USD | -3562.75% |
| 2024 Q1 | 357 Million USD | -7.27% |
| 2024 Q4 | -245 Million USD | -125.23% |
| 2023 FY | - USD | -140.5% |
| 2023 Q4 | 385 Million USD | -0.77% |
| 2023 Q1 | -4.66 Billion USD | -614.4% |
| 2023 Q2 | 1.3 Billion USD | 128.04% |
| 2023 Q3 | 388 Million USD | -70.34% |
| 2022 FY | - USD | 16.89% |
| 2022 Q1 | 4.4 Billion USD | 220.7% |
| 2022 Q3 | 568 Million USD | -63.84% |
| 2022 Q4 | -653 Million USD | -214.96% |
| 2022 Q2 | 1.57 Billion USD | -64.3% |
| 2021 Q1 | -471 Million USD | -167.97% |
| 2021 Q4 | 1.37 Billion USD | -23.82% |
| 2021 Q3 | 1.8 Billion USD | 66.3% |
| 2021 FY | - USD | 64.82% |
| 2021 Q2 | 1.08 Billion USD | 329.94% |
| 2020 FY | - USD | -54.48% |
| 2020 Q1 | 1.52 Billion USD | 72.71% |
| 2020 Q2 | 1.75 Billion USD | 14.82% |
| 2020 Q3 | -1.14 Billion USD | -165.11% |
| 2020 Q4 | 693 Million USD | 160.79% |
| 2019 FY | - USD | -13.06% |
| 2019 Q4 | 883 Million USD | -53.7% |
| 2019 Q3 | 1.9 Billion USD | 24.07% |
| 2019 Q2 | 1.53 Billion USD | -19.78% |
| 2019 Q1 | 1.91 Billion USD | 5.27% |
| 2018 Q4 | 1.82 Billion USD | -10.74% |
| 2018 Q3 | 2.03 Billion USD | -16.13% |
| 2018 FY | - USD | 16.13% |
| 2018 Q2 | 2.43 Billion USD | 51.84% |
| 2018 Q1 | 1.6 Billion USD | 42.31% |
| 2017 Q2 | 1.87 Billion USD | 0.48% |
| 2017 FY | - USD | -3.46% |
| 2017 Q4 | 1.12 Billion USD | -41.47% |
| 2017 Q3 | 1.92 Billion USD | 2.45% |
| 2017 Q1 | 1.86 Billion USD | 32.98% |
| 2016 FY | - USD | -2.61% |
| 2016 Q4 | 1.4 Billion USD | -30.08% |
| 2016 Q1 | 1.79 Billion USD | 159.1% |
| 2016 Q2 | 1.8 Billion USD | 0.73% |
| 2016 Q3 | 2 Billion USD | 11.18% |
| 2015 Q2 | 3.09 Billion USD | 105.04% |
| 2015 FY | - USD | 52.28% |
| 2015 Q1 | 1.5 Billion USD | 194.15% |
| 2015 Q3 | 1.86 Billion USD | -39.82% |
| 2015 Q4 | 692 Million USD | -62.84% |
| 2014 Q1 | 1.48 Billion USD | 6.01% |
| 2014 Q3 | 1.48 Billion USD | -3.81% |
| 2014 Q2 | 1.54 Billion USD | 4.46% |
| 2014 Q4 | 513 Million USD | -65.52% |
| 2014 FY | - USD | -5.52% |
| 2013 Q4 | 1.39 Billion USD | 0.79% |
| 2013 FY | - USD | 14.97% |
| 2013 Q1 | 1.01 Billion USD | 13.62% |
| 2013 Q2 | 1.52 Billion USD | 49.51% |
| 2013 Q3 | 1.38 Billion USD | -8.94% |
| 2012 Q3 | 1.16 Billion USD | -15.78% |
| 2012 Q4 | 896 Million USD | -23.35% |
| 2012 Q1 | 1.17 Billion USD | -24.26% |
| 2012 Q2 | 1.38 Billion USD | 17.93% |
| 2012 FY | - USD | -15.06% |
| 2011 Q1 | 1.21 Billion USD | 20.2% |
| 2011 FY | - USD | 21.46% |
| 2011 Q4 | 1.55 Billion USD | 27.38% |
| 2011 Q3 | 1.22 Billion USD | -16.61% |
| 2011 Q2 | 1.46 Billion USD | 20.51% |
| 2010 Q3 | 1.09 Billion USD | -18.14% |
| 2010 Q2 | 1.33 Billion USD | 26.57% |
| 2010 Q1 | 1.05 Billion USD | 12.61% |
| 2010 FY | - USD | 6.3% |
| 2010 Q4 | 1.01 Billion USD | -7.51% |
| 2009 Q4 | 936 Million USD | -15.68% |
| 2009 FY | - USD | -1.37% |
| 2009 Q3 | 1.11 Billion USD | -12.67% |
| 2009 Q2 | 1.27 Billion USD | 40.44% |
| 2009 Q1 | 905 Million USD | -4.05% |
| 2008 FY | - USD | 11.87% |
| 2008 Q1 | 923.5 Million USD | 17.87% |
| 2008 Q2 | 1.28 Billion USD | 39.62% |
| 2008 Q3 | 1.12 Billion USD | -12.78% |
| 2008 Q4 | 943.2 Million USD | -16.13% |
| 2007 Q2 | 1.17 Billion USD | 41.69% |
| 2007 FY | - USD | 16.89% |
| 2007 Q3 | 1.03 Billion USD | -12.47% |
| 2007 Q4 | 783.5 Million USD | -24.08% |
| 2007 Q1 | 832.1 Million USD | 4.71% |
| 2006 Q3 | 707.6 Million USD | -13.8% |
| 2006 Q2 | 820.9 Million USD | 51.51% |
| 2006 Q1 | 541.8 Million USD | 3.3% |
| 2006 FY | - USD | 12.65% |
| 2006 Q4 | 794.7 Million USD | 12.31% |
| 2005 Q4 | 524.5 Million USD | -16.86% |
| 2005 Q3 | 630.9 Million USD | -17.66% |
| 2005 Q2 | 766.2 Million USD | 58.77% |
| 2005 Q1 | 482.6 Million USD | -6.36% |
| 2005 FY | - USD | 14.89% |
| 2004 Q3 | 541.7 Million USD | -18.46% |
| 2004 Q1 | 405 Million USD | -8.18% |
| 2004 Q2 | 664.3 Million USD | 64.02% |
| 2004 FY | - USD | 16.85% |
| 2004 Q4 | 515.4 Million USD | -4.86% |
| 2003 Q3 | 448.7 Million USD | -24.32% |
| 2003 Q1 | 336 Million USD | -14.72% |
| 2003 FY | - USD | 12.44% |
| 2003 Q2 | 592.9 Million USD | 76.46% |
| 2003 Q4 | 441.1 Million USD | -1.69% |
| 2002 Q4 | 394 Million USD | -4.85% |
| 2002 Q2 | 523.4 Million USD | 82.69% |
| 2002 Q1 | 286.5 Million USD | -15.31% |
| 2002 FY | - USD | 17.01% |
| 2002 Q3 | 414.1 Million USD | -20.88% |
| 2001 FY | - USD | 15.82% |
| 2001 Q1 | 257.6 Million USD | -16.88% |
| 2001 Q2 | 434.8 Million USD | 68.79% |
| 2001 Q4 | 338.3 Million USD | -2.08% |
| 2001 Q3 | 345.5 Million USD | -20.54% |
| 2000 Q4 | 309.9 Million USD | -0.93% |
| 2000 Q2 | 391.2 Million USD | 86.11% |
| 2000 FY | - USD | 15.93% |
| 2000 Q3 | 312.8 Million USD | -20.04% |
| 2000 Q1 | 210.2 Million USD | -19.28% |
| 1999 Q2 | 330 Million USD | 94.12% |
| 1999 Q3 | 256.3 Million USD | -22.33% |
| 1999 Q4 | 260.4 Million USD | 1.6% |
| 1999 FY | - USD | 24.16% |
| 1999 Q1 | 170 Million USD | -18.66% |
| 1998 Q1 | 143 Million USD | -15.53% |
| 1998 Q4 | 209 Million USD | 2.45% |
| 1998 Q3 | 204 Million USD | -26.88% |
| 1998 Q2 | 279 Million USD | 95.1% |
| 1998 FY | - USD | 13.97% |
| 1997 FY | - USD | 16.04% |
| 1997 Q4 | 169.3 Million USD | -2.53% |
| 1997 Q3 | 173.7 Million USD | -26.92% |
| 1997 Q2 | 237.7 Million USD | 95.64% |
| 1997 Q1 | 121.5 Million USD | -15.86% |
| 1996 Q3 | 146.7 Million USD | -28.51% |
| 1996 Q1 | 102.8 Million USD | -15.46% |
| 1996 FY | - USD | 15.4% |
| 1996 Q4 | 144.4 Million USD | -1.57% |
| 1996 Q2 | 205.2 Million USD | 99.61% |
| 1995 Q1 | 87.1 Million USD | -21.39% |
| 1995 Q4 | 121.6 Million USD | -3.65% |
| 1995 Q3 | 126.2 Million USD | -30.04% |
| 1995 Q2 | 180.4 Million USD | 107.12% |
| 1995 FY | - USD | 13.78% |
| 1994 Q1 | 70.6 Million USD | -24.57% |
| 1994 Q4 | 110.8 Million USD | -1.69% |
| 1994 Q3 | 112.7 Million USD | -27.99% |
| 1994 Q2 | 156.5 Million USD | 121.67% |
| 1994 FY | - USD | 11.28% |
| 1993 Q2 | 141.9 Million USD | 130.0% |
| 1993 FY | - USD | 15.99% |
| 1993 Q4 | 93.6 Million USD | -7.6% |
| 1993 Q3 | 101.3 Million USD | -31.18% |
| 1993 Q1 | 64 Million USD | -20.5% |
| 1992 Q1 | 56.9 Million USD | -25.62% |
| 1992 FY | - USD | 11.07% |
| 1992 Q4 | 80.5 Million USD | -8.94% |
| 1992 Q3 | 88.4 Million USD | -27.78% |
| 1992 Q2 | 122.4 Million USD | 115.11% |
| 1991 Q2 | 108.9 Million USD | 118.67% |
| 1991 FY | - USD | 16.96% |
| 1991 Q4 | 75.4 Million USD | -0.65% |
| 1991 Q3 | 77 Million USD | -29.29% |
| 1991 Q1 | 49.8 Million USD | -39.27% |
| 1990 Q1 | 63.6 Million USD | 101.59% |
| 1990 Q3 | 87.8 Million USD | -25.8% |
| 1990 Q2 | 116.7 Million USD | 87.38% |
| 1990 Q4 | 86.3 Million USD | -2.03% |
| 1990 FY | - USD | 10.03% |
| 1989 Q1 | 1.21 Billion USD | 135.05% |
| 1989 Q3 | 1.35 Billion USD | -8.53% |
| 1989 Q4 | -3.78 Billion USD | -380.27% |
| 1989 FY | - USD | 10.39% |
| 1989 Q2 | 1.47 Billion USD | 21.87% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Newron Pharmaceuticals S.p.A. | -11.71 Million EUR | -96129.523% |
| Redcare Pharmacy NV | 58.17 Million EUR | 19486.001% |